Publication & Citation Trends
Publications
0 total
HSR23-120: Real-World Observations Show Beneficial Outcomes in Patients With NSCLC Treated With Pembrolizumab for More Than 2 Years
Cited by 0
Semantic Scholar
Quality initiative (QI) to improve molecular testing in newly diagnosed (ND) stage 4 non-small cell lung cancer (NSCLC-4): An Integra Connect (IC) database study.
Cited by 0
Semantic Scholar
Quality initiative (QI) in unresectable stage III non-small cell lung cancer (NCSLC): Impact on time-to-treatment (TTT) for immunotherapy post chemoradiation (CRT).
Cited by 0
Semantic Scholar
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies OA
Cited by 36
Semantic Scholar
Brief Report: SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-study). OA
Cited by 56
Semantic Scholar
Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer.
Cited by 71
Semantic Scholar
Patient Reported-Quality of Life in Oligometastatic Cancer Treated with SBRT: Interim Report of a Phase II Multicenter Clinical Trial
Cited by 0
Semantic Scholar
Phase I study of veliparib in combination with gemcitabine OA
Cited by 13
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(22)
Lung Cancer Diagnosis and Treatment
(13)
Lung Cancer Research Studies
(9)
Cancer Immunotherapy and Biomarkers
(8)
Brain Metastases and Treatment
(5)
Affiliations
Pennsylvania State University
University of Pittsburgh
UPMC Hillman Cancer Center
University of Pittsburgh Medical Center
Pittsburg State University